These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 36228573

  • 1. ISSFAL statement number 7 - Omega-3 fatty acids during pregnancy to reduce preterm birth.
    Best KP, Gibson RA, Makrides M.
    Prostaglandins Leukot Essent Fatty Acids; 2022 Nov; 186():102495. PubMed ID: 36228573
    [Abstract] [Full Text] [Related]

  • 2. Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review.
    Newberry SJ, Chung M, Booth M, Maglione MA, Tang AM, O'Hanlon CE, Wang DD, Okunogbe A, Huang C, Motala A, Trimmer M, Dudley W, Shanman R, Coker TR, Shekelle PG.
    Evid Rep Technol Assess (Full Rep); 2016 Oct; (224):1-826. PubMed ID: 30307735
    [Abstract] [Full Text] [Related]

  • 3. Study protocol for a randomised controlled trial evaluating the effect of prenatal omega-3 LCPUFA supplementation to reduce the incidence of preterm birth: the ORIP trial.
    Zhou SJ, Best K, Gibson R, McPhee A, Yelland L, Quinlivan J, Makrides M.
    BMJ Open; 2017 Sep 24; 7(9):e018360. PubMed ID: 28947468
    [Abstract] [Full Text] [Related]

  • 4. Effect of omega-3 lcpufa supplementation on maternal fatty acid and oxylipin concentrations during pregnancy.
    Best KP, Gibson RA, Yelland LN, Leemaqz S, Gomersall J, Liu G, Makrides M.
    Prostaglandins Leukot Essent Fatty Acids; 2020 Nov 24; 162():102181. PubMed ID: 33038832
    [Abstract] [Full Text] [Related]

  • 5. Omega-3 fatty acid supplementation in pregnancy-baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial.
    Simmonds LA, Sullivan TR, Skubisz M, Middleton PF, Best KP, Yelland LN, Quinlivan J, Zhou SJ, Liu G, McPhee AJ, Gibson RA, Makrides M.
    BJOG; 2020 Jul 24; 127(8):975-981. PubMed ID: 32034969
    [Abstract] [Full Text] [Related]

  • 6. Plasma oxylipins and unesterified precursor fatty acids are altered by DHA supplementation in pregnancy: Can they help predict risk of preterm birth?
    Ramsden CE, Makrides M, Yuan ZX, Horowitz MS, Zamora D, Yelland LN, Best K, Jensen J, Taha AY, Gibson RA.
    Prostaglandins Leukot Essent Fatty Acids; 2020 Feb 24; 153():102041. PubMed ID: 31931275
    [Abstract] [Full Text] [Related]

  • 7. Plasma long-chain omega-3 fatty acid status and risk of recurrent early spontaneous preterm birth: a prospective observational study.
    Goodfellow L, Care A, Harrold J, Sharp A, Ivandic J, Poljak B, Roberts D, Alfirevic A, Müller-Myhsok B, Gibson R, Makrides M, Alfirevic Z.
    Acta Obstet Gynecol Scand; 2021 Aug 24; 100(8):1401-1411. PubMed ID: 33742474
    [Abstract] [Full Text] [Related]

  • 8. Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in Indonesia.
    Aziz MA, Hidayat D, Irwantoro G, Nugrahani AD, Wijaya JJ, Alamsyah SNK, Almira NL, Sutjighassani T, Santoso DPJ, Krisnadi SR.
    Med Sci Monit; 2024 May 11; 30():e943895. PubMed ID: 38733071
    [Abstract] [Full Text] [Related]

  • 9. Docosahexaenoic acid (DHA) intake estimated from a 7-question survey identifies pregnancies most likely to benefit from high-dose DHA supplementation.
    Christifano DN, Crawford SA, Lee G, Brown AR, Camargo JT, Kerling EH, Gajewski BJ, Valentine CJ, Gustafson KM, DeFranco EA, Carlson SE.
    Clin Nutr ESPEN; 2023 Feb 11; 53():93-99. PubMed ID: 36657936
    [Abstract] [Full Text] [Related]

  • 10. Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth.
    Cetin I, Carlson SE, Burden C, da Fonseca EB, di Renzo GC, Hadjipanayis A, Harris WS, Kumar KR, Olsen SF, Mader S, McAuliffe FM, Muhlhausler B, Oken E, Poon LC, Poston L, Ramakrishnan U, Roehr CC, Savona-Ventura C, Smuts CM, Sotiriadis A, Su KP, Tribe RM, Vannice G, Koletzko B, Clinical Practice Guideline on behalf of Asia Pacific Health Association (Pediatric-Neonatology Branch), Child Health Foundation (Stiftung Kindergesundheit), European Academy of Paediatrics, European Board & College of Obstetrics and Gynaecology, European Foundation for the Care of Newborn Infants, European Society for Paediatric Research, and International Society for Developmental Origins of Health and Disease.
    Am J Obstet Gynecol MFM; 2024 Feb 11; 6(2):101251. PubMed ID: 38070679
    [Abstract] [Full Text] [Related]

  • 11. The effectiveness of ω-3 polyunsaturated fatty acid interventions during pregnancy on obesity measures in the offspring: an up-to-date systematic review and meta-analysis.
    Vahdaninia M, Mackenzie H, Dean T, Helps S.
    Eur J Nutr; 2019 Oct 11; 58(7):2597-2613. PubMed ID: 30251019
    [Abstract] [Full Text] [Related]

  • 12. Impact of n-3 polyunsaturated fatty acid intake in pregnancy on maternal health and birth outcomes: systematic review and meta-analysis from randomized controlled trails.
    Abdelrahman MA, Osama H, Saeed H, Madney YM, Harb HS, Abdelrahim MEA.
    Arch Gynecol Obstet; 2023 Jan 11; 307(1):249-262. PubMed ID: 35348829
    [Abstract] [Full Text] [Related]

  • 13. Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth: A position statement by the European Board and College of Obstetrics and Gynaecology (EBCOG).
    Savona-Ventura C, Mahmood T, Mukhopadhyay S, Louwen F.
    Eur J Obstet Gynecol Reprod Biol; 2024 Apr 11; 295():124-125. PubMed ID: 38354604
    [Abstract] [Full Text] [Related]

  • 14. Docosahexaenoic Acid and Preterm Birth.
    Makrides M, Best K.
    Ann Nutr Metab; 2016 Apr 11; 69 Suppl 1():29-34. PubMed ID: 27842314
    [Abstract] [Full Text] [Related]

  • 15. Identifying women who may benefit from higher dose omega-3 supplementation during pregnancy to reduce their risk of prematurity: exploratory analyses from the ORIP trial.
    Yelland LN, Sullivan TR, Gibson RA, Simmonds LA, Thakkar SK, Huang F, Devaraj S, Best KP, Zolezzi IS, Makrides M.
    BMJ Open; 2023 Apr 17; 13(4):e070220. PubMed ID: 37068907
    [Abstract] [Full Text] [Related]

  • 16. Omega-3 fatty acids to prevent preterm birth: Australian pregnant women's preterm birth awareness and intentions to increase omega-3 fatty acid intake.
    de Seymour JV, Simmonds LA, Gould J, Makrides M, Middleton P.
    Nutr J; 2019 Nov 14; 18(1):74. PubMed ID: 31727060
    [Abstract] [Full Text] [Related]

  • 17. DHA supplementation and pregnancy outcomes.
    Carlson SE, Colombo J, Gajewski BJ, Gustafson KM, Mundy D, Yeast J, Georgieff MK, Markley LA, Kerling EH, Shaddy DJ.
    Am J Clin Nutr; 2013 Apr 14; 97(4):808-15. PubMed ID: 23426033
    [Abstract] [Full Text] [Related]

  • 18. Translating n-3 polyunsaturated fatty acid status from whole blood to plasma and red blood cells during pregnancy: Translating n-3 status across blood fractions in pregnancy.
    Simmonds LA, Yelland LN, Best KP, Liu G, Gibson RA, Makrides M.
    Prostaglandins Leukot Essent Fatty Acids; 2022 Jan 14; 176():102367. PubMed ID: 34864617
    [Abstract] [Full Text] [Related]

  • 19. Predictors of compliance with higher dose omega-3 fatty acid supplementation during pregnancy and implications for the risk of prematurity: exploratory analysis of the ORIP randomised trial.
    Sullivan TR, Yelland LN, Gibson RA, Thakkar SK, Huang F, Best KP, Devaraj S, Zolezzi IS, Makrides M.
    BMJ Open; 2023 Sep 22; 13(9):e076507. PubMed ID: 37739459
    [Abstract] [Full Text] [Related]

  • 20. Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS): study protocol for a double-blind, randomized, placebo-controlled parallel clinical trial of n-3 polyunsaturated fatty acids in pregnant smokers.
    Murff HJ, Greevy RA, Sanghani RS, Hartmann KE, Hartert TV, Graves CR, Lee SS, Tindle HA.
    Trials; 2021 Dec 14; 22(1):922. PubMed ID: 34906201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.